Search Results 251-260 of 19720 for CLL

  1. Case-Control Study of Hodgkin Lymphoma, Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia - Lymphoma Epidemiology Laboratory - Mayo Clinic Research

    Dr. Cerhan's NHL & CLL case-control study at Mayo Clinic tests hypotheses about the etiology of non-Hodgkin lymphoma and chronic lymphocytic leukemia.

  2. Clinical trials - Oncology (Medical)

    A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls. Rochester, Minn ...

  3. Case-Control Study of Hodgkin Lymphoma, Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia - Lymphoma Epidemiology Laboratory - Mayo Clinic Research

    Dr. Cerhan's NHL & CLL case-control study at Mayo Clinic tests hypotheses about the etiology of non-Hodgkin lymphoma and chronic lymphocytic leukemia.

  4. Clinical trials - Oncology (Medical)

    A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls. Rochester, Minn ...

  5. New Mayo Clinic studies to be presented at American Society of Hematology meeting

    Chronic lymphocytic leukemia is a type of cancer of the ... "This supports our hypothesis that the scores are significant predictors for CLL prognosis.

  6. Clinical trials - Oncology (Medical)

    ... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.

  7. Clinical trials - Oncology (Medical)

    ... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.

  8. A Study to Evaluate Daratumumab and Ibrutinib to Treat Relapsed / Refractory Chronic Lymphocytic Leukemia Treatment (DIRECT) - Mayo Clinic

    A Study to Evaluate Daratumumab and Ibrutinib to Treat Relapsed / Refractory Chronic Lymphocytic Leukemia Treatment (DIRECT). Print details. Share; Facebook ...

  9. Clinical trials - Oncology (Medical)

    ... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.

  10. Pirtobrutinib (oral route) - Side effects & dosage - Mayo Clinic

    For mantle cell lymphoma, chronic lymphocytic leukemia (CLL), and small lymphocytic lymphoma (SLL):. Adults—200 milligrams (mg) once a day. Your doctor may ...